Chinook Therapeutics Overview

Chinook Therapeutics Other Income Expense Net

Other Income/Expense Net for KDNY.

Quarterly Other Income/Expense

$1.43M

↑ 86.05% YoY

As of Jun 30, 2023

Annual Other Income/Expense (TTM)

$8.67M

↑ 302.71% YoY

Trailing 12 months ending Jun 30, 2023

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin